BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 35500679)

  • 1. Recent progress in the early detection of cancer based on CD44 biomarker; nano-biosensing approaches.
    Kazemi Y; Dehghani S; Nosrati R; Taghdisi SM; Abnous K; Alibolandi M; Ramezani M
    Life Sci; 2022 Jul; 300():120593. PubMed ID: 35500679
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The recent advancements in the early detection of cancer biomarkers by DNAzyme-assisted aptasensors.
    Kamali H; Golmohammadzadeh S; Zare H; Nosrati R; Fereidouni M; Safarpour H
    J Nanobiotechnology; 2022 Oct; 20(1):438. PubMed ID: 36195928
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Aptasensors as a new sensing technology developed for the detection of MUC1 mucin: A review.
    Yousefi M; Dehghani S; Nosrati R; Zare H; Evazalipour M; Mosafer J; Tehrani BS; Pasdar A; Mokhtarzadeh A; Ramezani M
    Biosens Bioelectron; 2019 Apr; 130():1-19. PubMed ID: 30716589
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The recent progress in the early diagnosis of acute myocardial infarction based on myoglobin biomarker: Nano-aptasensors approaches.
    Asl SK; Rahimzadegan M
    J Pharm Biomed Anal; 2022 Mar; 211():114624. PubMed ID: 35123334
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aptamer-based biosensors and nanosensors for the detection of vascular endothelial growth factor (VEGF): A review.
    Dehghani S; Nosrati R; Yousefi M; Nezami A; Soltani F; Taghdisi SM; Abnous K; Alibolandi M; Ramezani M
    Biosens Bioelectron; 2018 Jul; 110():23-37. PubMed ID: 29579646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ultra-wide, attomolar-level limit detection of CD44 biomarker with a silanized optical fiber biosensor.
    Bekmurzayeva A; Ashikbayeva Z; Assylbekova N; Myrkhiyeva Z; Dauletova A; Ayupova T; Shaimerdenova M; Tosi D
    Biosens Bioelectron; 2022 Jul; 208():114217. PubMed ID: 35367702
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recent advances in electrochemical nanomaterial-based aptasensors for the detection of cancer biomarkers.
    Negahdary M; Angnes L
    Talanta; 2023 Jul; 259():124548. PubMed ID: 37062088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aptamers in nanostructure-based electrochemical biosensors for cardiac biomarkers and cancer biomarkers: A review.
    Negahdary M
    Biosens Bioelectron; 2020 Mar; 152():112018. PubMed ID: 32056737
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nano-biosensing approaches on tuberculosis: Defy of aptamers.
    Golichenari B; Nosrati R; Farokhi-Fard A; Abnous K; Vaziri F; Behravan J
    Biosens Bioelectron; 2018 Oct; 117():319-331. PubMed ID: 29933223
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dynamic Measurement of a Cancer Biomarker: Towards In Situ Application of a Fiber-Optic Ball Resonator Biosensor in CD44 Protein Detection.
    Myrkhiyeva Z; Kantoreyeva K; Bekmurzayeva A; Gomez AW; Ashikbayeva Z; Tilegen M; Pham TT; Tosi D
    Sensors (Basel); 2024 Mar; 24(6):. PubMed ID: 38544254
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Recent advances on aptamer-based biosensors to detection of platelet-derived growth factor.
    Razmi N; Baradaran B; Hejazi M; Hasanzadeh M; Mosafer J; Mokhtarzadeh A; de la Guardia M
    Biosens Bioelectron; 2018 Aug; 113():58-71. PubMed ID: 29729560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recent progress on developing of plasmon biosensing of tumor biomarkers: Efficient method towards early stage recognition of cancer.
    Fattahi Z; Khosroushahi AY; Hasanzadeh M
    Biomed Pharmacother; 2020 Dec; 132():110850. PubMed ID: 33068930
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determination of soluble CD44 in serum by using a label-free aptamer based electrochemical impedance biosensor.
    Zhou J; Cheng K; Chen X; Yang R; Lu M; Ming L; Chen Y; Lin Z; Chen D
    Analyst; 2020 Jan; 145(2):460-465. PubMed ID: 31781712
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Optical and electrochemical-based nano-aptasensing approaches for the detection of circulating tumor cells (CTCs).
    Safarpour H; Dehghani S; Nosrati R; Zebardast N; Alibolandi M; Mokhtarzadeh A; Ramezani M
    Biosens Bioelectron; 2020 Jan; 148():111833. PubMed ID: 31733465
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Aptasensors for Cancerous Exosome Detection.
    Li J; Xie S; Qu F; Tan W
    Methods Mol Biol; 2022; 2504():3-20. PubMed ID: 35467275
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toward Early Diagnosis of Colorectal Cancer: Focus on Optical Nano Biosensors.
    Darroudi M; Ghasemi K; Rezayi M; Khazaei M
    Mini Rev Med Chem; 2023; 23(9):1033-1049. PubMed ID: 35549882
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of various optical and electrochemical aptasensors for detection of human prostate specific antigen: A review.
    Ghorbani F; Abbaszadeh H; Dolatabadi JEN; Aghebati-Maleki L; Yousefi M
    Biosens Bioelectron; 2019 Oct; 142():111484. PubMed ID: 31284103
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Applications of graphene-based electrochemical and optical biosensors in early detection of cancer biomarkers.
    Arshad F; Nabi F; Iqbal S; Khan RH
    Colloids Surf B Biointerfaces; 2022 Apr; 212():112356. PubMed ID: 35123193
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent Advances in Biosensors for Detecting Cancer-Derived Exosomes.
    Cheng N; Du D; Wang X; Liu D; Xu W; Luo Y; Lin Y
    Trends Biotechnol; 2019 Nov; 37(11):1236-1254. PubMed ID: 31104858
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Recent advances in nanomaterials-based electrochemical immunosensors and aptasensors for HER2 assessment in breast cancer.
    Ahirwar R
    Mikrochim Acta; 2021 Sep; 188(10):317. PubMed ID: 34476602
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.